Related Experiment Videos

Molecular basis of canine muscle type phosphofructokinase deficiency

B F Smith1, H Stedman, Y Rajpurohit

  • 1Section of Medical Genetics, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6010, USA.

Insights

Canine muscle type phosphofructokinase (M-PFK) deficiency, a genetic disorder causing exertional myopathy, results from a mutation causing M-PFK protein degradation. A DNA test can now identify affected dogs and carriers for this rare metabolic disease.

Area of Science:

  • Biochemistry
  • Genetics
  • Veterinary Medicine

Background:

  • Muscle type phosphofructokinase (M-PFK) deficiency is a rare inherited glycogen storage disease.
  • This condition causes exertional myopathy and hemolysis in humans.
  • Canine M-PFK deficiency is the only known natural animal model.

Purpose of the Study:

  • To investigate the molecular basis of M-PFK deficiency in dogs.
  • To develop a diagnostic test for canine M-PFK deficiency.

Main Methods:

  • Investigated the M-PFK gene in affected dogs.
  • Identified a nonsense mutation in the penultimate exon.
  • Developed a polymerase chain reaction (PCR)-based genetic test.

Main Results:

  • A nonsense mutation in the M-PFK gene was identified as the cause.
  • The mutation leads to rapid degradation of an unstable, truncated M-PFK protein.
  • A reliable PCR-based test was successfully developed to detect deficient and carrier animals.

Conclusions:

  • The molecular defect in canine M-PFK deficiency is a nonsense mutation leading to protein instability.
  • This canine model is valuable for studying inborn errors of metabolism and developing therapies.
  • A genetic test enables identification of affected and carrier dogs, aiding breeding programs and research.

Related Concept Videos